See more : Pluristem Therapeutics Inc. (PSTI) Income Statement Analysis – Financial Results
Complete financial analysis of ADDCN Technology Co., Ltd (5287.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ADDCN Technology Co., Ltd, a leading company in the None industry within the None sector.
You may be interested
- Texas Capital Bancshares, Inc. (TCBI) Income Statement Analysis – Financial Results
- Shinto Paint Company, Limited (4615.T) Income Statement Analysis – Financial Results
- Jacquet Metals SA (JCQ.PA) Income Statement Analysis – Financial Results
- Enjoyor Technology Co., Ltd. (300020.SZ) Income Statement Analysis – Financial Results
- Ambika Cotton Mills Limited (AMBIKCO.NS) Income Statement Analysis – Financial Results
ADDCN Technology Co., Ltd (5287.TWO)
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 2.15B | 1.96B | 1.68B | 1.54B | 1.47B |
Cost of Revenue | 647.01M | 574.97M | 449.84M | 344.73M | 342.70M |
Gross Profit | 1.50B | 1.38B | 1.23B | 1.20B | 1.13B |
Gross Profit Ratio | 69.90% | 70.64% | 73.30% | 77.61% | 76.66% |
Research & Development | 103.87M | 69.23M | 66.90M | 51.79M | 45.65M |
General & Administrative | 298.03M | 279.35M | 256.62M | 222.13M | 0.00 |
Selling & Marketing | 266.18M | 277.11M | 206.86M | 199.58M | 0.00 |
SG&A | 564.21M | 556.46M | 463.47M | 421.70M | 362.54M |
Other Expenses | 0.00 | 30.97M | 28.36M | 24.19M | 0.00 |
Operating Expenses | 668.08M | 625.68M | 530.38M | 473.49M | 408.19M |
Cost & Expenses | 1.32B | 1.20B | 980.21M | 818.22M | 750.89M |
Interest Income | 10.74M | 4.67M | 3.14M | 4.01M | 4.92M |
Interest Expense | 2.80M | 1.85M | 845.00K | 166.00K | 289.00K |
Depreciation & Amortization | 61.22M | 55.49M | 55.49M | 53.18M | 46.93M |
EBITDA | 962.91M | 876.93M | 817.62M | 832.14M | 764.07M |
EBITDA Ratio | 44.79% | 44.78% | 48.54% | 54.04% | 53.50% |
Operating Income | 834.79M | 821.44M | 762.13M | 778.96M | 717.14M |
Operating Income Ratio | 38.83% | 41.94% | 45.24% | 50.59% | 48.85% |
Total Other Income/Expenses | 64.10M | 61.86M | 56.91M | 57.24M | 38.41M |
Income Before Tax | 898.89M | 819.59M | 764.89M | 778.79M | 738.17M |
Income Before Tax Ratio | 41.81% | 41.85% | 45.40% | 50.58% | 50.28% |
Income Tax Expense | 193.44M | 168.29M | 160.35M | 156.62M | 154.70M |
Net Income | 710.78M | 664.55M | 612.43M | 627.40M | 601.16M |
Net Income Ratio | 33.06% | 33.93% | 36.35% | 40.75% | 40.95% |
EPS | 11.86 | 11.93 | 11.03 | 9.56 | 10.11 |
EPS Diluted | 11.75 | 11.83 | 10.90 | 9.50 | 10.04 |
Weighted Avg Shares Out | 59.92M | 55.72M | 55.52M | 55.48M | 59.43M |
Weighted Avg Shares Out (Dil) | 60.48M | 56.16M | 56.20M | 55.83M | 59.86M |
No news found for: 5287.TWO
Source: https://incomestatements.info
Category: Stock Reports